Journal of Clinical Endocrinology & Metabolism, Vol 71, 1259-1264, Copyright © 1990 by Endocrine Society

ARTICLES

Failure of dehydroepiandrosterone to influence energy and protein metabolism in humans

S Welle, R Jozefowicz and M Statt
Department of Medicine, University of Rochester, New York 14620.

It was reported recently that 4 weeks of dehydroepiandrosterone (DHEA) treatment [5.55 mmol/day (1600 mg/day), orally] reduced body fat and increased lean body mass in healthy men. The present study was performed to examine whether these effects could be explained by increased energy expenditure and muscle protein synthesis. Eight healthy men were given placebo and DHEA (1600 mg/day) for 4 weeks each in a double blind cross-over study. DHEA treatment caused a 9-fold increase in mean plasma DHEA sulfate concentrations, but had no significant effect on body weight or on two indices of lean body mass (total body water and total body potassium). DHEA had no effect on any of the parameters of energy and protein metabolism, including resting metabolic rate, total energy expenditure (estimated by the 2H2(18)O method during the final 2 weeks of each treatment period), leucine flux (an index of whole body proteolysis), the nonoxidized portion of leucine flux (an index of whole body protein synthesis), and the rate of incorporation of leucine into muscle protein. Circulating levels of cholesterol, T3, and T4 also were unaffected by DHEA. These data suggest that DHEA is not an important regulator of energy or protein metabolism in humans.

This article has been cited by other articles:

				A. B. O'Donnell, T. G. Travison, S. S. Harris, J. L. Tenover, and J. B. McKinlay Testosterone, Dehydroepiandrosterone, and Physical Performance in Older Men: Results from the Massachusetts Male Aging Study J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 425 - 431. [Abstract] [Full Text] [PDF]

				A. M Johnstone, S. D Murison, J. S Duncan, K. A Rance, and J. R Speakman Factors influencing variation in basal metabolic rate include fat-free mass, fat mass, age, and circulating thyroxine but not sex, circulating leptin, or triiodothyronine Am. J. Clinical Nutrition, November 1, 2005; 82(5): 941 - 948. [Abstract] [Full Text] [PDF]

				S. E. Riechman, T. J. Fabian, P. D. Kroboth, and R. E. Ferrell Steroid sulfatase gene variation and DHEA responsiveness to resistance exercise in MERET Physiol Genomics, May 19, 2004; 17(3): 300 - 306. [Abstract] [Full Text] [PDF]

				F. Labrie, V. Luu-The, C. Labrie, A. Belanger, J. Simard, S.-X. Lin, and G. Pelletier Endocrine and Intracrine Sources of Androgens in Women: Inhibition of Breast Cancer and Other Roles of Androgens and Their Precursor Dehydroepiandrosterone Endocr. Rev., April 1, 2003; 24(2): 152 - 182. [Abstract] [Full Text] [PDF]

				C. Crone, G. Gabriel, and T. N. Wise Non-Herbal Nutritional Supplements--The Next Wave: A Comprehensive Review of Risks and Benefits for the C-L Psychiatrist Psychosomatics, August 1, 2001; 42(4): 285 - 299. [Abstract] [Full Text] [PDF]

				A. R. Tagliaferro and A. M. Ronan Physiological levels and action of dehydroepiandrosterone in Yucatan miniature swine Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2001; 281(1): R1 - R9. [Abstract] [Full Text] [PDF]

				F. Callies, M. Fassnacht, J. C. van Vlijmen, I. Koehler, D. Huebler, M. J. Seibel, W. Arlt, and B. Allolio Dehydroepiandrosterone Replacement in Women with Adrenal Insufficiency: Effects on Body Composition, Serum Leptin, Bone Turnover, and Exercise Capacity J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 1968 - 1972. [Abstract] [Full Text]

				A. Khalil, J.-P. Fortin, J.-G. LeHoux, and T. Fülöp Age-related decrease of dehydroepiandrosterone concentrations in low density lipoproteins and its role in the susceptibility of low density lipoproteins to lipid peroxidation J. Lipid Res., October 1, 2000; 41(10): 1552 - 1561. [Abstract] [Full Text]

				P. Kintz, V. Cirimele, M. Deveaux, and B. Ludes Clin. Chem., March 1, 2000; 46(3): 414 - 415. [Full Text] [PDF]

				G. A. Bray and F. L. Greenway Current and Potential Drugs for Treatment of Obesity Endocr. Rev., December 1, 1999; 20(6): 805 - 875. [Abstract] [Full Text]

				G. A. Brown, M. D. Vukovich, R. L. Sharp, T. A. Reifenrath, K. A. Parsons, and D. S. King Effect of oral DHEA on serum testosterone and adaptations to resistance training in young men J Appl Physiol, December 1, 1999; 87(6): 2274 - 2283. [Abstract] [Full Text] [PDF]

				R. Johnson Abnormal Testosterone:Epitestosterone Ratios after Dehydroepiandrosterone Supplementation Clin. Chem., February 1, 1999; 45(2): 163 - 164. [Full Text] [PDF]

				W. Arlt, H.-G. Justl, F. Callies, M. Reincke, D. Hübler, M. Oettel, M. Ernst, H. M. Schulte, and B. Allolio Oral Dehydroepiandrosterone for Adrenal Androgen Replacement: Pharmacokinetics and Peripheral Conversion to Androgens and Estrogens in Young Healthy Females after Dexamethasone Suppression J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 1928 - 1934. [Abstract] [Full Text]

				S. Welle and C. A. Thornton High-protein meals do not enhance myofibrillar synthesis after resistance exercise in 62- to 75-yr-old men and women Am J Physiol Endocrinol Metab, April 1, 1998; 274(4): E677 - E683. [Abstract] [Full Text] [PDF]

				E. D. Schriock, C. K. Buffington, J. R. Givens, and J. E. Buster Enhanced Post-Receptor Insulin Effects in Women Following Dehydroepiandrosterone Infusion Reproductive Sciences, January 1, 1994; 1(1): 74 - 78. [Abstract] [PDF]